Dow Up 1.31% Nasdaq Up 2.40%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
174.48 Up 6.28(3.73%) 4:00PM EDT
|After Hours : 174.52 Up 0.04 (0.03%) 5:13PM EDT
Prev Close:168.20
Open:169.92
Bid:157.00 x 100
Ask:178.50 x 400
1y Target Est:198.57
Beta:1.07
Next Earnings Date:23-Oct-14ALXN Earnings announcement
Day's Range:167.97 - 174.50
52wk Range:106.83 - 185.43
Volume:1,271,754
Avg Vol (3m):1,182,010
Market Cap:34.51B
P/E (ttm):87.46
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 3.73%34.51B
AMGNUp 4.79%109.45B
BAXUp 1.05%37.19B

Key Statistics

Forward P/E (1 yr):30.45
P/S (ttm):17.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback